H&H國際控股(01112.HK)就發行人民幣5億元債券訂立認購協議
格隆匯3月21日丨H&H國際控股(01112.HK)發佈公吿,2024年3月20日,公司與聯席牽頭經辦人就發行人民幣5億元於2027年到期的7.5%有擔保債券訂立認購協議,有關債券由公司若干現有附屬公司無條件且不可撤銷地擔保。債券將不會在任何證券交易所上市。債券將不會評級。
根據是次發售提呈發售的債券的所得款項總額將約為人民幣5億元(於扣除包銷折讓以及其他費用及開支前)。公司擬使用債券的所得款項淨額(即所得款項總額減包銷折讓以及其他費用及開支)償還公司現有境外債務,並將僅遵照證券法S規例透過境外交易向在美國境外的投資者進行發售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.